'Industry-first' electronic consent platform reduces risk, says CRF Health

By Melissa Fassbender

- Last updated on GMT

Improved patient understanding helps reduced risk in clinical trials. (Image: iStock/AndreyPopov)
Improved patient understanding helps reduced risk in clinical trials. (Image: iStock/AndreyPopov)

Related tags Crf health Informed consent

CRF Health has launched TrialConsent, an electronic solution promoting better comprehension, compliance, and retention rates in clinical trials.

The eCOA solution provider said that the platform is “an industry-first” ​in which eConsent and eCOA are incorporated in one platform.

The platform incorporates recommendations from the US FDA’s Guidance on informed consent in order to achieve better participant understanding of complex information.

Awareness of issues associated with informed consent has been growing​,” Rachael Wyllie, CEO, CRF Health, told Outsourcing-Pharma.com. “Currently, there is increasing complexity in clinical trial language and extensive paper-forms leading to a lack of patient comprehension, reduced protocol compliance, and increased drop-out rates.​”

The program uses tiered information delivery to allow participants to learn about the trial by presenting content concisely and in a way which Wyllie said is more effective than reviewing a lengthy paper-document.

Improved patient understanding is a driver in reducing risk in studies​,” she added. “Patients who are better informed are less likely to drop out once enrolled because they've been better prepared to make their decision to participate.​”

For example, the program uses interactive assessment check points at regular intervals throughout the consent process in order to allow patients to gauge their own understanding, in addition to allowing site staff to assess the participant's understanding of material.

Participants can digitally earmark content they do not understand or want additional explanation of​,” said Wyllie. Multimedia video, audio, narration, and images are also incorporated.

By approaching simplified explanations from different angles using mixed media, the technology ensures patients truly understand the protocol complexities of a particular trial in the process of agreeing to participate​,” added Wyllie.

While the new program is geared at benefiting the patient, Wyllie explained that improved patient understanding helps reduce risk in clinical trials.

TrialConsent uses time-stamps to provide a clear, digital audit trail and makes the data defensible to regulatory authorities​,” she explained. “Additionally, version control and electronic processes for content edits, approvals, and deployment means patients are not able to consent to an outdated or un-approved consent document​.”

The program also enables study teams and ethics committees to monitor site and patient consent statistics and compliance. 

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us


View more